Sugemalimab is the world\'s first anti-PD-L1 monoclonal antibody approved for the treatment of gastric or gastroesophageal junction (G/GEJ) adenocarcinoma. The GEMSTONE-303 study results support sugem
BARCELONA,Spain,Feb. 25,2025-- IIIF150,the imaginative ultra-thin rugged phone manufacture,announced their new flagship Raptor 5G which will be showcased in Barcelona,and different tests onsite to cha
BEIJING,Feb. 25,2025-- A report from People\'s Daily: Recently,a foreign scholar described China as an "enabler." This term vividly encapsulates China\'s commitment to building a community w
At the forefront of the launch are Flexport Intelligence with an AI Insights Builder, and Flexport Control Tower expanding supply chain visibility and management capabilities.
SHANGHAI,Feb. 23,2025-- BioCityBiopharma (BioCity) announced that its selective endothelin receptor type A (ETA) antagonist,SC0062,met the 12-week primary endpoint of a reduction in proteinuria in the
https://iris.who.int/handle/10665/380481 TOKYO,Feb. 25,2025-- World Health Organization (WHO) Regional Office for the Western Pacific (WPRO) has released Japan\'s AMR Response 2013–2025 alongside Tok
New agreement spans packet core,signaling,charging & policy solutions STOCKHOLM,Feb. 25,2025-- India\'s Bharti Airtel and Ericsson (NASDAQ: ERIC) have strengthened their longstanding partnership t
BEIJING,Feb. 25,2025-- Baidu,Inc. (NASDAQ: BIDU and HKEX: 9888 (HKD Counter) and 89888 (RMB Counter)) ("Baidu"),a leading AI company with strong Internet foundation,today announced that Baid
SINGAPORE,Feb. 25,2025-- China Yuchai International Limited(NYSE: CYD) ("China Yuchai" or the "Company"),one of the largest powertrain solution manufacturers through its main opera
KARACHI,Pakistan,Feb. 25,2025--Kerry,a global leader in taste and nutrition,has partnered with Far Eastern Impex (FEI) to open the first international production operation for flavourings in Pakistan
